Based on the limited information available, Innogest Capital appears to be a venture capital firm that invests in both technology and healthcare companies. Within healthcare, they have a focus on cardiovascular-related projects. Their investments seem to be geared towards companies with innovative technologies and products that address unmet needs in their respective markets. The firm supports portfolio companies like Greenbone, Empatica, and Medlumics which focus on regeneration in large gap non-union fractures, an AI-based platform for chronic diseases like epilepsy, and an ablation catheter for Atrial Fibrillation respectively. They also invest in companies with next-generation technologies such as Anaconda Biomed, BetaGlue Technologies, and Newronika. Overall, Innogest Capital seeks to invest in and support companies that are developing cutting-edge technologies with the potential to significantly impact healthcare and technology industries.
Bevorzugte Reifephase für die erste Finanzierung.
Healthcare, Technology, Cardiovascular, Medical Devices, AI based Platform
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...